Advisor Group Holdings, Inc. Immunocore Holdings PLC Transaction History
Advisor Group Holdings, Inc.
- $42.1 Billion
- Q1 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,448 shares of IMCR stock, worth $55,950. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,448
Previous 1,329
8.95%
Holding current value
$55,950
Previous $39,000
7.69%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding IMCR
# of Institutions
128Shares Held
44.6MCall Options Held
219KPut Options Held
125K-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.05MShares$272 Million0.14% of portfolio
-
Wellington Management Group LLP Boston, MA6.13MShares$237 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$188 Million2.37% of portfolio
-
Primecap Management CO Pasadena, CA2.68MShares$104 Million0.07% of portfolio
-
Baker Bros. Advisors LP New York, NY2.32MShares$89.7 Million0.82% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.7B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...